ClinicalTrials.Veeva

Menu

Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients

U

Universitaire Ziekenhuizen KU Leuven

Status

Completed

Conditions

Hypercalcemia
Kidney Disease

Treatments

Procedure: high calcium dialysate

Study type

Interventional

Funder types

Other

Identifiers

NCT00485706
ML4181
S50455

Details and patient eligibility

About

Renal patients have an increased risk for cardiovascular complications. There is also increased vascular calcification and bone metabolism is similarly abnormal in patients with chronic kidney disease.

In dialysis patients frequent episodes of hypercalcaemia occur. In a healthy bone structure those episodes of hypercalcemia are buffered by the bone. The absence of bone buffering capacity in dialysis patients can be a mechanism for vascular calcifications.

Full description

Study hypothesis.

Patient with a higher ∆ Calcium (Calcium post - Calcium pre) have a diminished bone buffering capacity indicative for adynamic bone disease compared with patients with smaller ∆ Calcium.

This may result in higher extraosseous calcification and higher pulse wave velocity

∆ PTH/∆ Calcium may reflect the sensitivity and density of the calcium receptors; this may reflect parathyroid "health"

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • maintenance hemodialysis patients

Exclusion criteria

  • dialysis <3 months
  • aortobifemoral graft
  • calcium level predialysis >10.5 mg/dl

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems